As breast density notification requirements continue to evolve, understanding how dense breast tissue impacts cancer detection has never been more important. Breast density influences both breast cancer risk and mammographic performance, making it a key factor in determining when supplemental screening may be beneficial.
In this course, Dr. Ashley Huppe provides a practical, evidence-based review of breast density and its role in modern breast cancer screening. Explore how dense tissue affects mammographic sensitivity, contributes to interval cancers, and impacts overall screening outcomes. You’ll also examine current recommendations* for supplemental screening with ultrasound (US), MRI, and ABUS, including the strengths, limitations, and appropriate use of each modality.
Through real-world examples and guideline-based discussions, you’ll gain the confidence to navigate supplemental screening decisions, tailor recommendations to individual patient risk factors, and support more effective, patient-centered care for women with dense breasts.
- 1.25 Category A CEUs
- Faculty: Ashley Huppe, MD
*As of December 2025
Please note: This CE activity may be available in multiple formats or from different CE sponsors. ARRT regulations state that an individual may not repeat a CE activity for credit if it was reported in the same CE biennium.
